Case number 2019-1133
Biogen MA Inc. v. EMD Serono, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | BIOGEN MA INC. v. EMD SERONO, INC. [OPINION] [precedential] (0) |
| Apr 23, 2021 | 0 | BIOGEN MA INC. v. EMD SERONO, INC. [ERRATA] [nonprecedential] (0) |
| Apr 23, 2021 | 0 | BIOGEN MA INC. v. EMD SERONO, INC. [ERRATA] [nonprecedential] (0) |
| Dec 30, 2020 | 101 | Notice from Appellee Biogen MA Inc. of Withdrawal of David Ball as Counsel. Service: 12/30/2020 by email. [746006] [19-1133] [Nicholas Groombridge] [Entered: 12/30/2020 12:16 PM] (3) |
| Dec 28, 2020 | 100 | Mandate issued to the United States District Court for the District of New Jersey. Service as of this date by the Clerk of Court. [745380] [JAB] [Entered: 12/28/2020 11:19 AM] (1) |
| Dec 18, 2020 | 99 | ORDER filed denying [95] petition for panel rehearing, for en banc rehearing filed by Biogen MA Inc. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [743704] [JAB] [Entered: 12/18/2020 09:55 AM] (2) |
| Nov 20, 2020 | 98 | ERRATA to the Precedential Opinion [90]. Service as of this date by the Clerk of Court. [737194] [JAB] [Entered: 11/20/2020 09:57 AM] (1) |
| Nov 13, 2020 | 97 | RESPONSE of Appellants EMD Serono, Inc. and Pfizer Inc. to the petition [95], petition [95]. Service: 11/13/2020 by email. [735534] [19-1133] [Mark Perry] [Entered: 11/13/2020 04:47 PM] (26) |
| Oct 30, 2020 | 96 | The court invites a response from Appellants EMD Serono, Inc. and Pfizer Inc. to the petition for panel rehearing, for en banc rehearing filed by Appellee in 19-1133. Response due on 11/13/2020. Service as of this date by the Clerk of Court. [732595] [JAB] [Entered: 10/30/2020 02:32 PM] (1) |
| Oct 28, 2020 | 95 | Petition for panel rehearing, for en banc rehearing filed by Appellee Biogen MA Inc.. Service: 10/28/2020 by email. [732062] [19-1133] [Nicholas Groombridge] [Entered: 10/28/2020 01:38 PM] (47) |
| Oct 13, 2020 | 94 | Bill of Costs for Appellants EMD Serono, Inc. and Pfizer Inc.. Service: 10/13/2020 by email. [728091] [19-1133] [Mark Perry] [Entered: 10/13/2020 09:37 AM] (1) |
| Oct 9, 2020 | 93 | ERRATA to the Precedential Opinion [90]. Service as of this date by the Clerk of Court. [727803] [JAB] [Entered: 10/09/2020 09:23 AM] (1) |
| Oct 7, 2020 | 92 | Letter from Appellants EMD Serono, Inc. and Pfizer Inc. Regarding Apparent Typographical Error in Opinion. Service: 10/07/2020 by email. [727467] [19-1133] [Mark Perry] [Entered: 10/07/2020 04:03 PM] (2) |
| Sep 28, 2020 | 90 | OPINION filed for the court by Newman, Circuit Judge; Linn, Circuit Judge and Hughes, Circuit Judge. Precedential Opinion. [724710] [JCP] [Entered: 09/28/2020 09:41 AM] (20) |
| Sep 28, 2020 | 91 | JUDGMENT. REVERSED AND REMANDED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellee(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [724712] [JCP] [Entered: 09/28/2020 09:43 AM] (2) |
| Mar 6, 2020 | 89 | Submitted after ORAL ARGUMENT by Mr. Mark Andrew Perry for Pfizer Inc. and EMD Serono, Inc. and Nicholas P. Groombridge for Biogen MA Inc. Panel: Judge: Newman , Judge: Linn , Judge: Hughes. [676863] [JCP] [Entered: 03/06/2020 10:29 AM] (0) |
| Feb 12, 2020 | 88 | Response to notice of oral argument from the Appellee Biogen MA Inc.. [670791] [19-1133] [Nicholas Groombridge] [Entered: 02/12/2020 02:11 PM] (3) |
| Jan 29, 2020 | 87 | Response to notice of oral argument from the Appellants EMD Serono, Inc. and Pfizer Inc.. [666779] [19-1133] [Mark Perry] [Entered: 01/29/2020 09:53 AM] (3) |
| Jan 21, 2020 | 86 | NOTICE OF ORAL ARGUMENT. Panel: 2003N. Case scheduled March 6, 2020 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 402. Response to Notice of Oral Argument due: 02/14/2020. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [664700] [JAB] [Entered: 01/21/2020 02:39 PM] (2) |
| Nov 22, 2019 | 85 | RESPONSE of Appellee Biogen MA Inc. to the supplemental authority [84] filed by Appellants EMD Serono, Inc. and Pfizer Inc. Service: 11/22/2019 by email. [651723] [19-1133] [Nicholas Groombridge] [Entered: 11/22/2019 12:38 PM] (4) |
| Nov 11, 2019 | 84 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellants EMD Serono, Inc. and Pfizer Inc.. Service: 11/11/2019 by email. [648434] [19-1133] [Mark Perry] [Entered: 11/11/2019 05:37 PM] (21) |
| Sep 6, 2019 | 79 | Notice from Appellants EMD Serono, Inc. and Pfizer Inc. regarding conflicts with oral argument. Service: 09/06/2019 by email. [633629] [19-1133] [Mark Perry] [Entered: 09/06/2019 11:49 AM] (3) |
| Sep 6, 2019 | 80 | RESPONSE of Appellee Biogen MA Inc. to the supplemental authority [73] filed by Appellants EMD Serono, Inc. and Pfizer Inc. Service: 09/06/2019 by email. [633652] [19-1133] [Nicholas Groombridge] [Entered: 09/06/2019 01:02 PM] (3) |
| Sep 6, 2019 | 81 | The following conflict dates submitted by Attorney Mark Andrew Perry for Appellants Pfizer Inc. and EMD Serono, Inc. have been accepted by the court: 01/06/2020, 01/07/2020, 02/03/2020, 02/04/2020, 02/05/2020, 02/06/2020, 02/07/2020. [633654] [JAB] [Entered: 09/06/2019 01:07 PM] (0) |
| Sep 6, 2019 | 82 | Notice from Appellee Biogen MA Inc. regarding conflicts with oral argument. Service: 09/06/2019 by email. [633709] [19-1133] [Nicholas Groombridge] [Entered: 09/06/2019 02:35 PM] (4) |
| Sep 6, 2019 | 83 | The following conflict dates submitted by Attorney Nicholas P. Groombridge for Appellee Biogen MA Inc. have been accepted by the court: 02/03/2020, 02/04/2020, 02/05/2020, 02/06/2020, 02/07/2020. [633757] [JAB] [Entered: 09/06/2019 03:32 PM] (0) |
| Sep 5, 2019 | 74 | 6 paper copies of the Opening Response Brief [54] received from Appellee Biogen MA Inc.. [633359] [CJF] [Entered: 09/05/2019 12:40 PM] (0) |
| Sep 5, 2019 | 75 | 6 paper copies of the Amicus Brief [48] received from Amicus Curiae Bayer HealthCare Pharmaceuticals Inc.. [633383] [CJF] [Entered: 09/05/2019 01:11 PM] (0) |
| Sep 5, 2019 | 76 | 6 paper copies of the Reply Brief [56] received from Appellants EMD Serono, Inc. and Pfizer Inc.. [633436] [CJF] [Entered: 09/05/2019 02:20 PM] (0) |
| Sep 5, 2019 | 77 | 6 paper copies of the Opening Brief [29] received from Appellants EMD Serono, Inc. and Pfizer Inc.. [633437] [CJF] [Entered: 09/05/2019 02:21 PM] (0) |
| Sep 5, 2019 | 78 | 6 paper copies of the Corrected Confidential Appendix Brief (Vol. I - III) [69] received from Appellants EMD Serono, Inc., Pfizer Inc. and Appellee Biogen MA Inc.. [633439] [CJF] [Entered: 09/05/2019 02:22 PM] (0) |
| Sep 3, 2019 | 73 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellants EMD Serono, Inc. and Pfizer Inc.. Service: 09/03/2019 by email. [632858] [19-1133] [Mark Perry] [Entered: 09/03/2019 04:30 PM] (16) |
| Aug 30, 2019 | 71 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [632234] [MMA] [Entered: 08/30/2019 10:46 AM] (0) |
| Aug 30, 2019 | 72 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [632235] [MMA] [Entered: 08/30/2019 10:46 AM] (1) |
| Aug 28, 2019 | 69 | MODIFIED ENTRY: CORRECTED CONFIDENTIAL APPENDIX FILED for EMD Serono, Inc., Pfizer Inc. and Biogen MA Inc. Number of Pages: 1695. Service: 08/28/2019 by email. [631774]--[Edited 08/30/2019 by MMA - Reason: compliance review complete] [Mark Perry] [Entered: 08/28/2019 05:26 PM] (0) |
| Aug 28, 2019 | 70 | MODIFIED ENTRY: CORRECTED APPENDIX FILED for EMD Serono, Inc., Pfizer Inc. and Biogen MA Inc. Number of Pages: 1668. Service: 08/28/2019 by email. [631776]--[Edited 08/30/2019 by MMA - Reason: compliance review complete] [Mark Perry] [Entered: 08/28/2019 05:39 PM] (1668) |
| Aug 27, 2019 | 68 | NOTICE OF NON-COMPLIANCE: The submission of Appellants EMD Serono, Inc., Pfizer Inc. and Appellee Biogen MA Inc., Corrected Confidential and Non-Confidential Joint Appendix [66], [67], is not in compliance with the rules of this court (see attached). Compliant appenidx due on 09/04/2019. Service as of this date by the Clerk of Court. [631349] [MMA] [Entered: 08/27/2019 02:10 PM] (2) |
| Aug 22, 2019 | 66 | FILED from Appellants EMD Serono, Inc., Pfizer Inc. and Appellee Biogen MA Inc. Title: CORRECTED CONFIDENTIAL APPENDIX. Service: 08/22/2019 by email. [630403] [19-1133] This appendix is non-compliant. See Doc. No. [68] [Mark Perry] [Entered: 08/22/2019 04:37 PM] (0) |
| Aug 22, 2019 | 67 | FILED from Appellants EMD Serono, Inc., Pfizer Inc. and Appellee Biogen MA Inc. Title: CORRECTED APPENDIX. Service: 08/22/2019 by email. [630412] [19-1133] This appendix is non-compliant. See Doc. No. [68] [Mark Perry] [Entered: 08/22/2019 04:43 PM] (1668) |
| Aug 20, 2019 | 65 | NOTICE OF NON-COMPLIANCE: The submission of Appellants EMD Serono, Inc., Pfizer Inc. and Appellee Biogen MA Inc., Correct Confidential and Non-Confidential Joint Appendix [63], [64], is not in compliance with the rules of this court (see attached). Compliant appendix due on 08/27/2019. Service as of this date by the Clerk of Court. [629580] [MMA] [Entered: 08/20/2019 12:42 PM] (2) |
| Aug 16, 2019 | 63 | FILED from Appellants EMD Serono, Inc., Pfizer Inc. and Appellee Biogen MA Inc. Title: CORRECTED CONFIDENTIAL APPENDIX. Service: 08/16/2019 by email. [629014] [19-1133] This appendix is non-compliant. See Doc. No. [65] [Mark Perry] [Entered: 08/16/2019 02:59 PM] (0) |
| Aug 16, 2019 | 64 | FILED from Appellants EMD Serono, Inc., Pfizer Inc. and Appellee Biogen MA Inc. Title: CORRECTED APPENDIX. Service: 08/16/2019 by email. [629025] [19-1133] This appendix is non-compliant. See Doc. No. [65] [Mark Perry] [Entered: 08/16/2019 03:13 PM] (1668) |
| Aug 9, 2019 | 62 | NOTICE OF NON-COMPLIANCE: The submission of EMD Serono, Inc. and Pfizer Inc., Joint Appendix (confidential [60], nonconfidential [61]), is not in compliance with the rules of this court (see attached). Compliant appendix due 08/16/2019. Service as of this date by the Clerk of Court. [627139] [MJL] [Entered: 08/09/2019 09:14 AM] (2) |
| Aug 7, 2019 | 57 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants EMD Serono, Inc., Pfizer Inc. and Appellee Biogen MA Inc.. Service: 08/07/2019 by email. [626649] [19-1133] [Mark Perry] [Entered: 08/07/2019 12:31 PM] (3) |
| Aug 7, 2019 | 58 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants EMD Serono, Inc. and Pfizer Inc.. Service: 08/07/2019 by email. [626650] [19-1133] [Mark Perry] [Entered: 08/07/2019 12:37 PM] (3) |
| Aug 7, 2019 | 59 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Biogen MA Inc.. Service: 08/07/2019 by email. [626661] [19-1133] [Nicholas Groombridge] [Entered: 08/07/2019 01:34 PM] (3) |
| Aug 7, 2019 | 60 | FILED from Appellants EMD Serono, Inc., Pfizer Inc. and Appellee Biogen MA Inc. Title: CONFIDENTIAL APPENDIX. Service: 08/07/2019 by email. [626851] [19-1133]. This appendix is non-compliant. See Doc. No. [62]. [Mark Perry] [Entered: 08/07/2019 06:19 PM] (0) |
| Aug 7, 2019 | 61 | FILED from Appellants EMD Serono, Inc., Pfizer Inc. and Appellee Biogen MA Inc. Title: APPENDIX. Service: 08/07/2019 by email. [626856] [19-1133]. This appendix is non-compliant. See Doc. No. [62]. [Mark Perry] [Entered: 08/07/2019 07:51 PM] (1213) |
| Jul 31, 2019 | 56 | MODIFIED ENTRY: REPLY BRIEF FILED for EMD Serono, Inc. and Pfizer Inc. Number of Pages: 31. Service: 07/31/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See FCR 31. [625042]--[Edited 08/01/2019 by MJL - compliance review complete] [Mark Perry] [Entered: 07/31/2019 07:07 PM] (43) |
| Jul 5, 2019 | 55 | **TEXT ONLY** ORDER granting motion to withdraw Aaron Frumkin as counsel for Pfizer Inc. and EMD Serono, Inc. [51]. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [619106] [MJL] [Entered: 07/05/2019 08:16 AM] (0) |
| Jul 3, 2019 | 54 | MODIFIED ENTRY: BRIEF FILED for Biogen MA Inc. Number of Pages: 69. Service: 07/03/2019 by email. [619068]--[Edited 07/05/2019 by MJL - compliance review complete] [Nicholas Groombridge] [Entered: 07/03/2019 04:52 PM] (82) |
| Jul 2, 2019 | 51 | MOTION of Appellants EMD Serono, Inc. and Pfizer Inc. to withdraw counsel Aaron Frumkin [Consent: unopposed]. Service: 07/02/2019 by email. [618697] [19-1133] [Mark Perry] [Entered: 07/02/2019 04:35 PM] (8) |
| Jul 2, 2019 | 52 | Entry of appearance for Kevin H. Marino as of counsel for Appellee Biogen MA Inc.. Service: 07/02/2019 by email. [618758] [19-1133] [Kevin Marino] [Entered: 07/02/2019 08:50 PM] (1) |
| Jul 2, 2019 | 53 | Entry of appearance for John D. Tortorella as of counsel for Appellee Biogen MA Inc.. Service: 07/02/2019 by email. [618762] [19-1133] [John Tortorella] [Entered: 07/02/2019 08:55 PM] (1) |
| Jun 13, 2019 | 50 | ORDER filed. The motion [49] is granted. Service: 06/13/2019 by clerk. [613907] [NL] [Entered: 06/13/2019 01:03 PM] (2) |
| May 30, 2019 | 49 | MODIFIED ENTRY: MOTION of Biogen MA Inc. to waive the requirements regarding the brief and permit a 15,000 word response brief [Consent: unopposed]. Service: 05/30/2019 by email. [610561]--[Edited 06/03/2019 by MJL to correct relief] [Nicholas Groombridge] [Entered: 05/30/2019 06:51 PM] (8) |
| May 22, 2019 | 47 | ORDER filed. The motion [36] is granted. Service: 05/22/2019 by clerk. [609092] [LMS] [Entered: 05/22/2019 03:25 PM] (2) |
| May 22, 2019 | 48 | AMICUS BRIEF FILED for Bayer HealthCare Pharmaceuticals Inc. Number of Pages: 29. Service: 04/15/2019 by email. [609114] [JAL] [Entered: 05/22/2019 04:01 PM] (38) |
| May 13, 2019 | 46 | ORDER granting motion to extend time to file brief [45] filed by Appellants Pfizer Inc. and EMD Serono, Inc. and Appellee Biogen MA Inc. Appellee's response brief is due 07/03/2019. Appellants' reply brief is due 07/31/2019. Service as of this date by the Clerk of Court. [606758] [JAL] [Entered: 05/13/2019 09:41 AM] (2) |
| May 10, 2019 | 45 | MOTION of Appellee Biogen MA Inc. and Appellants EMD Serono, Inc. and Pfizer Inc. to extend the time to 07/03/2019 to file the Red Brief and 07/31/2019 to file the Gray Brief. [Consent: unopposed]. Service: 05/10/2019 by email. [606564] [19-1133] [Nicholas Groombridge] [Entered: 05/10/2019 02:23 PM] (20) |
| Apr 30, 2019 | 43 | RESPONSE of Appellee Biogen MA Inc. to the motion for leave to file an amicus curiae brief [36]. Service: 04/30/2019 by email. [603973] [19-1133] [Nicholas Groombridge] [Entered: 04/30/2019 11:27 AM] (51) |
| Apr 30, 2019 | 44 | Notice of Correction to the response Doc No. [41] for Appellee Biogen MA Inc.. Service: 04/30/2019 by email. [603977] [19-1133] [Nicholas Groombridge] [Entered: 04/30/2019 11:30 AM] (3) |
| Apr 29, 2019 | 42 | REPLY of Bayer HealthCare Pharmaceuticals Inc. to response filed by Appellee, Doc. No [41]. Service: 04/29/2019 by email. [603821] [19-1133] [Bruce Genderson] [Entered: 04/29/2019 06:54 PM] (17) |
| Apr 26, 2019 | 41 | RESPONSE of Appellee Biogen MA Inc. to the motion for leave to file an amicus curiae brief [36]. Service: 04/26/2019 by email. [603424] [19-1133] [Nicholas Groombridge] [Entered: 04/26/2019 08:33 PM] (49) |
| Apr 19, 2019 | 38 | NOTICE OF NON-COMPLIANCE: The submission of EMD Serono, Inc. and Pfizer Inc., Notice of Correction [30], is not in compliance with the rules of this court (see attached). Compliant document due 04/26/2019.. Service as of this date by the Clerk of Court. [601645] [MJL] [Entered: 04/19/2019 01:38 PM] (1) |
| Apr 19, 2019 | 39 | Notice of Correction to the Brief Doc No. [29] for Appellants EMD Serono, Inc. and Pfizer Inc.. Service: 04/19/2019 by email. [601666] [19-1133] [Mark Perry] [Entered: 04/19/2019 02:10 PM] (3) |
| Apr 19, 2019 | 40 | ORDER filed. Any opposition to the motion [36] shall be filed no later than seven days from the date of issuance of this order. Any reply is due no later than three days from the filing of the response. Service: 04/19/2019 by clerk. [601698] [NL] [Entered: 04/19/2019 03:42 PM] (2) |
| Apr 15, 2019 | 29 | MODIFIED ENTRY: BRIEF FILED for EMD Serono, Inc. and Pfizer Inc. Number of Pages: 65. Service: 04/15/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of the original brief. See FCR 31. [600369]--[Edited 04/19/2019 by MJL - compliance review complete] [Mark Perry] [Entered: 04/15/2019 08:46 PM] (227) |
| Apr 15, 2019 | 30 | Notice of Correction to the Brief Doc No. [29] for Appellants EMD Serono, Inc. and Pfizer Inc.. Service: 04/15/2019 by email. [600370] [19-1133]. This document is non-compliant. See Doc. No. [38]. [Mark Perry] [Entered: 04/15/2019 08:49 PM] (2) |
| Apr 15, 2019 | 31 | Entry of appearance for Bruce R. Genderson as principal counsel for Not party Bayer HealthCare Pharmaceuticals Inc.. Service: 04/15/2019 by email. [600373] [19-1133] [Bruce Genderson] [Entered: 04/15/2019 09:27 PM] (2) |
| Apr 15, 2019 | 32 | Certificate of Interest for the Not party Bayer HealthCare Pharmaceuticals Inc.. Service: 04/15/2019 by email. [600374] [19-1133] [Bruce Genderson] [Entered: 04/15/2019 09:30 PM] (3) |
| Apr 15, 2019 | 33 | Entry of appearance for David I. Berl as of counsel for Not party Bayer HealthCare Pharmaceuticals Inc.. Service: 04/15/2019 by email. [600375] [19-1133] [David Berl] [Entered: 04/15/2019 09:33 PM] (2) |
| Apr 15, 2019 | 34 | Entry of appearance for David M. Krinsky as of counsel for Not party Bayer HealthCare Pharmaceuticals Inc.. Service: 04/15/2019 by email. [600376] [19-1133] [David Krinsky] [Entered: 04/15/2019 09:35 PM] (2) |
| Apr 15, 2019 | 35 | Entry of appearance for Seth R. Bowers as of counsel for Not party Bayer HealthCare Pharmaceuticals Inc.. Service: 04/15/2019 by email. [600377] [19-1133] [Seth Bowers] [Entered: 04/15/2019 09:37 PM] (2) |
| Apr 15, 2019 | 36 | MOTION of Bayer HealthCare Pharmaceuticals Inc. for leave to file an amicus curiae brief [Consent: partial consent]. Service: 04/15/2019 by email. [600378] [19-1133] [Bruce Genderson] [Entered: 04/15/2019 09:42 PM] (11) |
| Apr 15, 2019 | 37 | Bayer HealthCare Pharmaceuticals Inc. Title: AMICUS CURIAE BRIEF. Service: 04/15/2019 by email. [600379] [19-1133]--[Edited 05/22/2019 by JAL - Compliance review complete] [Bruce Genderson] [Entered: 04/15/2019 09:47 PM] (38) |
| Apr 8, 2019 | 28 | FILED from Appellants EMD Serono, Inc. and Pfizer Inc.. Title: OPENING BRIEF. Service: 04/08/2019 by email. [598535] [19-1133]. This brief has been corrected. See Doc. No. [29]. [Mark Perry] [Entered: 04/08/2019 05:50 PM] (247) |
| Mar 8, 2019 | 27 | ORDER filed. Appellants’ opening brief is due no later than 30 days from the date of filing of this order. Service: 03/08/2019 by clerk. [591644] [NL] [Entered: 03/08/2019 05:12 PM] (2) |
| Feb 7, 2019 | 26 | RESPONSE of Appellee Biogen MA, Inc to the court order to show cause [24] , court order [24]. Service: 02/07/2019 by email. [584171] [19-1133] [Nicholas Groombridge] [Entered: 02/07/2019 04:41 PM] (19) |
| Jan 31, 2019 | 25 | RESPONSE of Appellants EMD Serono, Inc. and Pfizer Inc. to the court order to show cause [24] , court order [24]. Service: 01/31/2019 by email. [582456] [19-1133] [Mark Perry] [Entered: 01/31/2019 03:07 PM] (17) |
| Jan 17, 2019 | 24 | ORDER filed. Within 14 days of the date of filing of this order, Serono is directed to show cause as to why this appeal should not be dismissed for lack of jurisdiction. Biogen may respond within 7 days thereafter. The briefing schedule is stayed. (Per Curiam). Service: 01/17/2019 by clerk. [578872] [LMS] [Entered: 01/17/2019 10:33 AM] (3) |
| Dec 18, 2018 | 23 | ORDER filed. The motion [20] is granted to the extent that the revised official caption and short caption are reflected in this order. Service: 12/18/2018 by clerk. [572596] [NL] [Entered: 12/18/2018 11:01 AM] (2) |
| Dec 7, 2018 | 20 | MOTION of Appellee Biogen Idec MA, Inc. to modify the official caption [Consent: unopposed]. Service: 12/07/2018 by email. [570266] [19-1133] [Nicholas Groombridge] [Entered: 12/07/2018 02:56 PM] (9) |
| Dec 7, 2018 | 21 | **TEXT ONLY** ORDER granting motion to extend time to file brief [19] filed by Appellants Pfizer Inc. and EMD Serono, Inc. Appellant's brief is due 03/01/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [570296] [JAL] [Entered: 12/07/2018 03:49 PM] (0) |
| Dec 7, 2018 | 22 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: motion to extend time to file brief Docket No. [19], ERROR: Appellants' motion [19] did not include a certificate of compliance or certificate of interest. CORRECTION: Pursuant to FRAP 32(g)(1) and FCR 27(a)(7), motions must contain a certificate of compliance with the word count and a certificate of interest. Please ensure future motions include the certificate of compliance and certificate of interest. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [570298] [JAL] [Entered: 12/07/2018 03:52 PM] (0) |
| Dec 6, 2018 | 19 | MOTION of Appellants EMD Serono, Inc. and Pfizer Inc. to extend the time to 03/01/2019 to file the the appellants' principal brief. [Consent: unopposed]. Service: 12/05/2018 by email. [569715] [19-1133] [Mark Perry] [Entered: 12/05/2018 12:54 PM] (8) |
| Nov 13, 2018 | 2 | Entry of appearance for Mark A. Perry as principal counsel for Appellants EMD Serono, Inc. and Pfizer Inc.. Service: 11/13/2018 by email. [564289] [19-1133] [Mark Perry] [Entered: 11/13/2018 11:17 AM] (1) |
| Nov 13, 2018 | 3 | Entry of appearance for Wayne M. Barsky as of counsel for Appellants EMD Serono, Inc. and Pfizer Inc.. Service: 11/13/2018 by email. [564291] [19-1133] [Mark Perry] [Entered: 11/13/2018 11:19 AM] (1) |
| Nov 13, 2018 | 4 | Entry of appearance for Timothy P. Best as of counsel for Appellants EMD Serono, Inc. and Pfizer Inc.. Service: 11/13/2018 by email. [564292] [19-1133] [Mark Perry] [Entered: 11/13/2018 11:20 AM] (1) |
| Nov 13, 2018 | 5 | Entry of appearance for Jaysen S. Chung as of counsel for Appellants EMD Serono, Inc. and Pfizer Inc.. Service: 11/13/2018 by email. [564296] [19-1133] [Mark Perry] [Entered: 11/13/2018 11:21 AM] (1) |
| Nov 13, 2018 | 6 | Entry of appearance for Christine L. Ranney as of counsel for Appellants EMD Serono, Inc. and Pfizer Inc.. Service: 11/13/2018 by email. [564297] [19-1133] [Mark Perry] [Entered: 11/13/2018 11:22 AM] (1) |
| Nov 13, 2018 | 7 | Entry of appearance for Aaron B. Frumkin as of counsel for Appellants EMD Serono, Inc. and Pfizer Inc.. Service: 11/13/2018 by email. [564298] [19-1133] [Mark Perry] [Entered: 11/13/2018 11:23 AM] (1) |
| Nov 13, 2018 | 8 | Certificate of Interest for the Appellant EMD Serono, Inc.. Service: 11/13/2018 by email. [564301] [19-1133] [Mark Perry] [Entered: 11/13/2018 11:24 AM] (2) |
| Nov 13, 2018 | 9 | Certificate of Interest for the Appellant Pfizer Inc.. Service: 11/13/2018 by email. [564302] [19-1133] [Mark Perry] [Entered: 11/13/2018 11:25 AM] (2) |
| Nov 13, 2018 | 10 | Docketing Statement for the Appellants EMD Serono, Inc. and Pfizer Inc.. Service: 11/13/2018 by email. [564304] [19-1133] [Mark Perry] [Entered: 11/13/2018 11:26 AM] (5) |
| Nov 13, 2018 | 11 | Entry of appearance for Nicholas Groombridge as principal counsel for Appellee Biogen Idec MA, Inc.. Service: 11/13/2018 by email. [564632] [19-1133] [Nicholas Groombridge] [Entered: 11/13/2018 05:42 PM] (2) |
| Nov 13, 2018 | 12 | Entry of appearance for David Ball as of counsel for Appellee Biogen Idec MA, Inc.. Service: 11/13/2018 by email. [564636] [19-1133] [Nicholas Groombridge] [Entered: 11/13/2018 05:45 PM] (2) |
| Nov 13, 2018 | 13 | Entry of appearance for Eric Alan Stone as of counsel for Appellee Biogen Idec MA, Inc.. Service: 11/13/2018 by email. [564637] [19-1133] [Nicholas Groombridge] [Entered: 11/13/2018 05:47 PM] (2) |
| Nov 13, 2018 | 14 | Entry of appearance for Josephine Young as of counsel for Appellee Biogen Idec MA, Inc.. Service: 11/13/2018 by email. [564643] [19-1133] [Nicholas Groombridge] [Entered: 11/13/2018 05:54 PM] (2) |
| Nov 13, 2018 | 15 | Entry of appearance for Jenny C. Wu as of counsel for Appellee Biogen Idec MA, Inc.. Service: 11/13/2018 by email. [564644] [19-1133] [Nicholas Groombridge] [Entered: 11/13/2018 05:56 PM] (2) |
| Nov 13, 2018 | 16 | Entry of appearance for Peter Sandel as of counsel for Appellee Biogen Idec MA, Inc.. Service: 11/13/2018 by email. [564645] [19-1133] [Nicholas Groombridge] [Entered: 11/13/2018 05:57 PM] (2) |
| Nov 13, 2018 | 17 | Certificate of Interest for the Appellee Biogen Idec MA, Inc.. Service: 11/13/2018 by email. [564646] [19-1133] [Nicholas Groombridge] [Entered: 11/13/2018 05:59 PM] (3) |
| Nov 13, 2018 | 18 | Docketing Statement for the Appellee Biogen Idec MA, Inc.. Service: 11/13/2018 by email. [564648] [19-1133] [Nicholas Groombridge] [Entered: 11/13/2018 06:00 PM] (5) |
| Oct 30, 2018 | 1 | Appeal docketed. Received: 10/23/2018. [561200]Entry of Appearance due 11/13/2018. Certificate of Interest due 11/13/2018. Docketing Statement due 11/13/2018. Appellants' brief due 12/31/2018. [MJL] [Entered: 10/30/2018 10:42 AM] (102) |
